• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前控制营养状况(CONUT)评分作为术前影像学检查≤7cm 非转移性透明细胞肾细胞癌患者生存的新型免疫营养预测因子。

Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.

机构信息

Department of Urology and Urological Science Institute, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.

Department of Urology, Tanta University College of Medicine, Tanta, 31512, Egypt.

出版信息

J Cancer Res Clin Oncol. 2019 Apr;145(4):957-965. doi: 10.1007/s00432-019-02846-x. Epub 2019 Feb 13.

DOI:10.1007/s00432-019-02846-x
PMID:30758671
Abstract

PURPOSE

This study aimed at investigating the prognostic value of Preoperative controlling nutritional status (CONUT) score in non-metastatic clear-cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.

METHODS

We retrospectively included 1046 among 1637 patients who underwent radical or partial nephrectomy for solid renal masses ≤ 7 cm (2005-2014) after excluding other pathology, conditions affecting CONUT score components, metastasis, regional lymphadenopathy, positive margin, and follow-up < 12 months. We defined high and low CONUT according to cut-off of (2). Multivariate Cox-regression analysis was used to predict factors affecting recurrence and survival. Kaplan-Meier curve was used for survival analysis.

RESULTS

The median age and follow-up were 56 years and 63 months, respectively. 41 patients had recurrence (3.9%). CONUT was a predictor for recurrence-free, cancer-specific, and overall survival (HR 3.09, P = 0.003 and HR 4.66, P = 0.004 and HR 2.81, P = 0.003, respectively). A higher CONUT was significantly associated with worse 5 years recurrence-free (88.2% vs. 97.1%), cancer-specific (96.2% vs. 98.8%) and overall (90.9% vs. 96.5%) survival (log-rank, P = < 0.001, P = 0.006 and P = < 0.001, respectively).

CONCLUSIONS

The preoperative CONUT is an independent prognostic marker for survival after curative surgery for non-metastatic clear-cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.

摘要

目的

本研究旨在探讨术前控制营养状况(CONUT)评分对术前影像学检查≤7cm 局限性透明细胞肾细胞癌的预后价值。

方法

我们回顾性纳入了 2005 年至 2014 年间 1637 例接受根治性或部分肾切除术治疗的直径≤7cm 实性肾肿块患者中的 1046 例(排除其他病理学、影响 CONUT 评分成分的情况、转移、区域淋巴结病、阳性切缘和随访<12 个月)。我们根据(2)的截断值将 CONUT 分为高和低。多变量 Cox 回归分析用于预测影响复发和生存的因素。Kaplan-Meier 曲线用于生存分析。

结果

中位年龄和随访时间分别为 56 岁和 63 个月。41 例患者复发(3.9%)。CONUT 是无复发生存、癌症特异性生存和总生存的预测因素(HR 3.09,P=0.003 和 HR 4.66,P=0.004 和 HR 2.81,P=0.003)。较高的 CONUT 与较差的 5 年无复发生存率(88.2%比 97.1%)、癌症特异性生存率(96.2%比 98.8%)和总生存率(90.9%比 96.5%)显著相关(log-rank,P<0.001、P=0.006 和 P<0.001)。

结论

术前 CONUT 是术前影像学检查≤7cm 局限性透明细胞肾细胞癌根治术后生存的独立预后标志物。

相似文献

1
Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.术前控制营养状况(CONUT)评分作为术前影像学检查≤7cm 非转移性透明细胞肾细胞癌患者生存的新型免疫营养预测因子。
J Cancer Res Clin Oncol. 2019 Apr;145(4):957-965. doi: 10.1007/s00432-019-02846-x. Epub 2019 Feb 13.
2
The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma.年龄调整 Charlson 共病指数作为手术治疗非转移性透明细胞肾细胞癌总生存的预测因子。
J Cancer Res Clin Oncol. 2020 Jan;146(1):187-196. doi: 10.1007/s00432-019-03042-7. Epub 2019 Oct 12.
3
Predictive value of preoperative monocyte-lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging.术前影像学检查显示肿瘤最大径≤7cm的局限性透明肾细胞癌患者术前单核细胞与淋巴细胞比值的预测价值
Medicine (Baltimore). 2018 Nov;97(48):e13433. doi: 10.1097/MD.0000000000013433.
4
Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.新型免疫和营养评分对根治性肾输尿管切除术治疗上尿路上皮癌患者预后的影响。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10893-10909. doi: 10.1007/s00432-023-04977-8. Epub 2023 Jun 15.
5
Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.多中心研究控制营养状况(CONUT)评分作为 HIV 相关肾细胞癌患者的预后因素。
Front Immunol. 2021 Nov 30;12:778746. doi: 10.3389/fimmu.2021.778746. eCollection 2021.
6
The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis.控制营养状况(CONUT)评分对手术治疗的肾细胞癌和上尿路尿路上皮癌的预后意义:系统评价和荟萃分析。
Eur J Clin Nutr. 2022 Jun;76(6):801-810. doi: 10.1038/s41430-021-01014-0. Epub 2021 Nov 23.
7
NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy.中性粒细胞与淋巴细胞比值作为接受减瘤性肾切除术治疗的转移性肾细胞癌患者的预后生物标志物。
Biomark Med. 2025 Mar;19(6):215-222. doi: 10.1080/17520363.2025.2471746. Epub 2025 Feb 26.
8
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较:系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.
9
Evaluating Long-Term Oncologic Outcomes of Radiofrequency Ablation for T1a Renal Cell Carcinoma with Minimum 10 Years of Follow-Up.评估T1a期肾细胞癌射频消融的长期肿瘤学结局:至少10年随访
J Endourol. 2025 Jun;39(6):594-600. doi: 10.1089/end.2024.0849. Epub 2025 Apr 24.
10
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.临床局限性肾肿块的部分肾切除术与根治性肾切除术对比
Cochrane Database Syst Rev. 2017 May 9;5(5):CD012045. doi: 10.1002/14651858.CD012045.pub2.

引用本文的文献

1
Predictive value of three nutritional indexes for disease activity in patients with inflammatory bowel disease.三种营养指标对炎症性肠病患者疾病活动度的预测价值
Ann Med. 2025 Dec;57(1):2443256. doi: 10.1080/07853890.2024.2443256. Epub 2024 Dec 20.
2
Abdominal Aortic Calcification as a Predictor of Incomplete Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Retrospective Cohort Study.腹主动脉钙化作为Ⅲ期结直肠癌辅助化疗不完整的预测指标:一项回顾性队列研究
Cureus. 2024 Oct 12;16(10):e71288. doi: 10.7759/cureus.71288. eCollection 2024 Oct.
3
The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma.

本文引用的文献

1
The prognostic role of controlling nutritional status scores in patients with solid tumors.控制营养状况评分在实体瘤患者中的预后作用。
Clin Chim Acta. 2017 Nov;474:155-158. doi: 10.1016/j.cca.2017.09.021. Epub 2017 Sep 28.
2
Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.术前血清胆固醇水平低与接受手术治疗的肾细胞癌患者侵袭性病理特征和癌症特异性生存不良相关。
Int J Clin Oncol. 2018 Feb;23(1):142-150. doi: 10.1007/s10147-017-1172-4. Epub 2017 Aug 8.
3
Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery.
控制营养状况(Conut)评分在肾癌根治性肾切除术后早期肾功能显著丧失的术前咨询中的附加价值
Cancers (Basel). 2024 Oct 17;16(20):3519. doi: 10.3390/cancers16203519.
4
Incidence and Pattern of Recurrence after Surgical Resection in Organ-Confined Renal Cell Carcinoma.器官局限性肾细胞癌手术后复发的发生率和模式。
Yonsei Med J. 2024 Nov;65(11):623-628. doi: 10.3349/ymj.2023.0587.
5
Prognostic value of Controlling Nutritional Status score for postoperative complications and biochemical recurrence in prostate cancer patients undergoing laparoscopic radical prostatectomy.控制营养状态评分对接受腹腔镜根治性前列腺切除术的前列腺癌患者术后并发症和生化复发的预后价值。
Curr Urol. 2024 Mar;18(1):43-48. doi: 10.1097/CU9.0000000000000231. Epub 2023 Oct 25.
6
CONUT score is associated with short-term prognosis in patients with severe acute pancreatitis: a propensity score matching cohort study.CONUT评分与重症急性胰腺炎患者的短期预后相关:一项倾向评分匹配队列研究。
Front Nutr. 2023 Apr 24;10:1115026. doi: 10.3389/fnut.2023.1115026. eCollection 2023.
7
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer.转移性胃食管交界部/胃癌患者免疫检查点抑制剂的营养指标
J Gastrointest Oncol. 2022 Oct;13(5):2072-2081. doi: 10.21037/jgo-22-217.
8
Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.多中心研究控制营养状况(CONUT)评分作为 HIV 相关肾细胞癌患者的预后因素。
Front Immunol. 2021 Nov 30;12:778746. doi: 10.3389/fimmu.2021.778746. eCollection 2021.
9
The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis.控制营养状况(CONUT)评分对手术治疗的肾细胞癌和上尿路尿路上皮癌的预后意义:系统评价和荟萃分析。
Eur J Clin Nutr. 2022 Jun;76(6):801-810. doi: 10.1038/s41430-021-01014-0. Epub 2021 Nov 23.
10
Controlling Nutritional Status (CONUT) score as a predictive marker for short-term complications following gastrectomy of gastric cancer: a retrospective study.控制营养状况(CONUT)评分作为胃癌胃切除术后短期并发症的预测指标:一项回顾性研究。
BMC Gastroenterol. 2021 Mar 5;21(1):107. doi: 10.1186/s12876-021-01682-z.
基于炎症标志物和营养状况的预后因素对预测接受非根治性手术的IV期胃癌患者预后的效用
Anticancer Res. 2017 Aug;37(8):4215-4222. doi: 10.21873/anticanres.11812.
4
Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.术前控制营养状况(CONUT)评分作为接受根治性肾输尿管切除术治疗的局限性上尿路尿路上皮癌患者生存的一种新型预测生物标志物。
Urol Oncol. 2017 Sep;35(9):539.e9-539.e16. doi: 10.1016/j.urolonc.2017.04.012. Epub 2017 May 9.
5
The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.控制营养状况评分是恶性胸膜间皮瘤患者预后不良的重要独立预测因素。
Clin Lung Cancer. 2017 Jul;18(4):e303-e313. doi: 10.1016/j.cllc.2017.01.008. Epub 2017 Feb 2.
6
The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.术前控制营养状况评分可预测Ⅰ期非小细胞肺癌患者根治性手术后的生存情况。
Anticancer Res. 2017 Feb;37(2):741-747. doi: 10.21873/anticanres.11372.
7
Impact of nutritional assessment and body mass index on cardiovascular outcomes in patients with stable coronary artery disease.营养评估和体重指数对稳定型冠状动脉疾病患者心血管结局的影响。
Int J Cardiol. 2017 Mar 1;230:653-658. doi: 10.1016/j.ijcard.2017.01.008. Epub 2017 Jan 4.
8
ESPEN guidelines on nutrition in cancer patients.ESPEN 肿瘤患者营养指南。
Clin Nutr. 2017 Feb;36(1):11-48. doi: 10.1016/j.clnu.2016.07.015. Epub 2016 Aug 6.
9
The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.术前控制营养状况(CONUT)评分是可切除胸段食管鳞状细胞癌患者的独立预后因素:一项回顾性研究结果
BMC Cancer. 2016 Sep 6;16(1):722. doi: 10.1186/s12885-016-2696-0.
10
Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.肌肉减少症和改良格拉斯哥预后评分是接受一线舒尼替尼治疗的转移性肾细胞癌患者生存的重要预测因素。
Target Oncol. 2016 Oct;11(5):605-617. doi: 10.1007/s11523-016-0430-0.